315 related articles for article (PubMed ID: 31614473)
1. Promise and the Pharmacological Mechanism of Botulinum Toxin A in Chronic Prostatitis Syndrome.
Chen CH; Tyagi P; Chuang YC
Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31614473
[TBL] [Abstract][Full Text] [Related]
2. Use of Botulinum Toxin A in the Treatment of Lower Urinary Tract Disorders: A Review of the Literature.
Moore DC; Cohn JA; Dmochowski RR
Toxins (Basel); 2016 Mar; 8(4):88. PubMed ID: 27023601
[TBL] [Abstract][Full Text] [Related]
3. Transurethral intraprostatic injection of botulinum neurotoxin type A for the treatment of chronic prostatitis/chronic pelvic pain syndrome: results of a prospective pilot double-blind and randomized placebo-controlled study.
Falahatkar S; Shahab E; Gholamjani Moghaddam K; Kazemnezhad E
BJU Int; 2015 Oct; 116(4):641-9. PubMed ID: 25307409
[TBL] [Abstract][Full Text] [Related]
4. Can Botulinum Toxin A Play A Role In Treatment Of Chronic Pelvic Pain Syndrome In Female Patients?-Clinical and Animal Evidence.
Chen CL; Meng E
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32050685
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin in urology: a review of clinical potential in the treatment of urologic and sexual conditions.
Chung E
Expert Opin Biol Ther; 2015 Jan; 15(1):95-102. PubMed ID: 25347039
[TBL] [Abstract][Full Text] [Related]
6. Multidisciplinary approach to prostatitis.
Magri V; Boltri M; Cai T; Colombo R; Cuzzocrea S; De Visschere P; Giuberti R; Granatieri CM; Latino MA; Larganà G; Leli C; Maierna G; Marchese V; Massa E; Matteelli A; Montanari E; Morgia G; Naber KG; Papadouli V; Perletti G; Rekleiti N; Russo GI; Sensini A; Stamatiou K; Trinchieri A; Wagenlehner FME
Arch Ital Urol Androl; 2019 Jan; 90(4):227-248. PubMed ID: 30655633
[TBL] [Abstract][Full Text] [Related]
7. [Intraprostatic botulinum toxin A injection in chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS)].
Bschleipfer T; Wagenlehner FM; Weidner W
Urologe A; 2007 Sep; 46(9):1030-2. PubMed ID: 17605125
[No Abstract] [Full Text] [Related]
8. Botulinum Toxin A for Bladder Pain Syndrome/Interstitial Cystitis.
Chiu B; Tai HC; Chung SD; Birder LA
Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27376330
[TBL] [Abstract][Full Text] [Related]
9. Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?
Chiang BJ; Kuo HC; Liao CH
Toxins (Basel); 2019 Sep; 11(9):. PubMed ID: 31546892
[TBL] [Abstract][Full Text] [Related]
10. Novel Applications of OnabotulinumtoxinA in Lower Urinary Tract Dysfunction.
Jhang JF; Kuo HC
Toxins (Basel); 2018 Jun; 10(7):. PubMed ID: 29949878
[TBL] [Abstract][Full Text] [Related]
11. Botulinum Toxin-A Injection in Chronic Pelvic Pain Syndrome Treatment: A Systematic Review and Pooled Meta-Analysis.
Panunzio A; Tafuri A; Mazzucato G; Cerrato C; Orlando R; Pagliarulo V; Antonelli A; Cerruto MA
Toxins (Basel); 2022 Jan; 14(1):. PubMed ID: 35051002
[TBL] [Abstract][Full Text] [Related]
12. Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Disease or Symptom? Current Perspectives on Diagnosis, Treatment, and Prognosis.
Zhang J; Liang C; Shang X; Li H
Am J Mens Health; 2020; 14(1):1557988320903200. PubMed ID: 32005088
[TBL] [Abstract][Full Text] [Related]
13. The effect of pirfenidone on rat chronic prostatitis/chronic pelvic pain syndrome and its mechanisms.
Peng X; Guo H; Chen J; Wang J; Huang J
Prostate; 2020 Sep; 80(12):917-925. PubMed ID: 32569423
[TBL] [Abstract][Full Text] [Related]
14. Current and potential urological applications of botulinum toxin A.
Jiang YH; Liao CH; Kuo HC
Nat Rev Urol; 2015 Sep; 12(9):519-33. PubMed ID: 26260879
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy strategies in chronic prostatitis/chronic pelvic pain syndrome management.
Murphy AB; Nadler RB
Expert Opin Pharmacother; 2010 Jun; 11(8):1255-61. PubMed ID: 20429665
[TBL] [Abstract][Full Text] [Related]
16. A nanoparticle-coupled T2 peptide induces immune tolerance and ameliorates chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in mice model.
Cao Y; Cheng Y; Ihsan AU; Khan FU; Xie D; Cui X; Wang W; Zhou X
Fundam Clin Pharmacol; 2019 Jun; 33(3):267-276. PubMed ID: 30471234
[TBL] [Abstract][Full Text] [Related]
17. Knowledge domain and emerging trends in chronic prostatitis/chronic pelvic pain syndrome from 1970 to 2020: a scientometric analysis based on VOSviewer and CiteSpace.
Liu SJ; Gao QH; Deng YJ; Zen Y; Zhao M; Guo J
Ann Palliat Med; 2022 May; 11(5):1714-1724. PubMed ID: 35144392
[TBL] [Abstract][Full Text] [Related]
18. Treatment of refractory category III nonbacterial chronic prostatitis/chronic pelvic pain syndrome with intraprostatic injection of onabotulinumtoxinA: a prospective controlled study.
Abdel-Meguid TA; Mosli HA; Farsi H; Alsayyad A; Tayib A; Sait M; Abdelsalam A
Can J Urol; 2018 Apr; 25(2):9273-9280. PubMed ID: 29680006
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Low-intensity Shockwave Therapy on Non-neurogenic Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis of Preclinical and Clinical Studies.
Sokolakis I; Pyrgidis N; Neisius A; Gierth M; Knoll T; Rassweiler J; Hatzichristodoulou G;
Eur Urol Focus; 2022 May; 8(3):840-850. PubMed ID: 33985934
[TBL] [Abstract][Full Text] [Related]
20. Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Magistro G; Wagenlehner FM; Grabe M; Weidner W; Stief CG; Nickel JC
Eur Urol; 2016 Feb; 69(2):286-97. PubMed ID: 26411805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
